Evogene's market cap is currently ―. The company's EPS TTM is $-0.531; its P/E ratio is -1.18; Evogene is scheduled to report earnings on May 28, 2024, and the estimated EPS forecast is $-0.10. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Sep 22	Jun 22	Mar 22
Income Statement	-
Total Revenue	-	-	$ 466.00K	$ 312.00K	$ 237.00K
Gross Profit	-	-	$ 346.00K	$ 50.00K	$ 74.00K
EBIT	-	-	$ -6.90M	$ -7.56M	$ -8.01M
EBITDA	-	-	$ -6.26M	$ -6.95M	$ -7.33M
Net Income Common Stockholders	-	-	$ -6.54M	$ -8.82M	$ -8.28M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 31.06M	$ 6.38M	$ 37.95M	$ 35.25M	$ 44.56M
Total Assets	$ 51.10M	$ 56.13M	$ 59.39M	$ 56.66M	$ 66.88M
Total Debt	$ 1.14M	$ 1.82M	$ 11.93M	$ 2.12M	$ 2.50M
Net Debt	$ -29.93M	$ -4.56M	$ -26.02M	$ -33.13M	$ -42.05M
Total Liabilities	$ 22.42M	$ 21.57M	$ 21.09M	$ 11.27M	$ 12.15M
Stockholders Equity	$ 12.05M	$ 27.93M	$ 30.58M	$ 36.95M	$ 45.53M
Cash Flow	-
Free Cash Flow	-	-	$ -7.28M	$ -6.96M	$ -8.15M
Operating Cash Flow	-	-	$ -7.06M	$ -6.66M	$ -7.71M
Investing Cash Flow	-	-	$ -22.00K	$ 1.76M	$ 11.98M
Financing Cash Flow	-	-	$ 10.17M	$ -369.00K	$ -100.00K

Currency in USD

Evogene Earnings and Revenue History

Income Statement >

Evogene Debt to Assets

Balance Sheet >

Evogene Cash Flow

Cash Flow >

Evogene Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing